Seeing Is Believing
Currently out of the existing stock ratings of Bruce D. Jackson, 12 are a BUY (100%).
Analyst Bruce D. Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 25% that have a potential upside of 65.47% achieved within 332 days.
Bruce D. Jackson’s has documented 20 price targets and ratings displayed on 2 stocks.
Most recent stock forecast was given on UNCY, Unicycive Therapeutics at 20-Aug-2026.
Analyst best performing recommendations are on UNCY (UNICYCIVE THERAPEUTICS).
The best stock recommendation documented was for UNCY (UNICYCIVE THERAPEUTICS) at 8/17/2021. The price target of $13 was fulfilled within 183 days with a profit of $12.6 (49.22%) receiving and performance score of 2.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Oct-2025
$13
$9.64 (286.90%)
$15
24 days ago
(29-Sep-2026)
0/4 (0%)
$8.45 (185.71%)
Buy Since 17-Aug-2021
$15
$10.2 (212.50%)
$13
2 months 3 days ago
(20-Aug-2026)
2/8 (25%)
$9.55 (175.23%)
332
Buy Since 17-Aug-2021
$15
$11.64 (346.43%)
$13
2 months 3 days ago
(20-Aug-2026)
0/11 (0%)
$9.55 (175.23%)
Buy Since 30-Jun-2026
$20
$16.64 (495.24%)
$22
2 months 10 days ago
(13-Aug-2026)
0/2 (0%)
$14.6 (270.37%)
Buy Since 29-Dec-2025
$25
$21.64 (644.05%)
$37
2 months 10 days ago
(13-Aug-2026)
0/4 (0%)
$19.6 (362.96%)
Which stock is Bruce D. Jackson most bullish on?
What Year was the first public recommendation made by Bruce D. Jackson?